Significantly, IGF-IR activation did not induce cell proliferation of bladder cancer cells, indicating that the IGF-IR acts as a “scatter factor” for urothelial carcinoma-derived cells and may regulate the transition to the invasive stage of bladder cancer [17]. This evidence concerns the gene IGF1R and urothelial carcinoma.